FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Miranda Verschraagen

Research Profile

Chemicals & Drugs

Procedures

Occupations

Concepts & Ideas

Co-author Network

Publications

TOP 3
Ingrid J Bosman; Miranda Verschraagen; Klaas J Lusthof
Toxicological findings in cases of sexual assault in the Netherlands.
Klaas J Lusthof; Roelof Oosting; Ann Maes; Miranda Verschraagen; Albert Dijkhuizen; Annette G A Sprong
A case of extreme agitation and death after the use of mephedrone in The Netherlands.
Miranda Verschraagen; Ann Maes; Bart Ruiter; Ingrid J Bosman; Beitske E Smink; Klaas J Lusthof
Post-mortem cases involving amphetamine-based drugs in The Netherlands. Comparison with driving under the influence cases.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Miranda Verschraagen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Ingrid J Bosman; Miranda Verschraagen; Klaas J Lusthof
Toxicological findings in cases of sexual assault in the Netherlands.
Journal of forensic sciences 2011;56(6):1562-8.
2011: Klaas J Lusthof; Roelof Oosting; Ann Maes; Miranda Verschraagen; Albert Dijkhuizen; Annette G A Sprong
A case of extreme agitation and death after the use of mephedrone in The Netherlands.
Forensic science international 2011;206(1-3):e93-5.
2007: Miranda Verschraagen; Ann Maes; Bart Ruiter; Ingrid J Bosman; Beitske E Smink; Klaas J Lusthof
Post-mortem cases involving amphetamine-based drugs in The Netherlands. Comparison with driving under the influence cases.
Forensic science international 2007;170(2-3):163-70.
2005: Epie Boven; Marjan J Westerman; Cees J van Groeningen; Miranda Verschraagen; Rita Ruijter; I Zegers; Wim J F van der Vijgh; Giuseppe Giaccone
Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 in combination with cisplatin and attempt to eliminate the hydration schedule.
British journal of cancer 2005;92(9):1636-43.
2004: Miranda Verschraagen; Epie Boven; Emine Torun; FREDERICK HAUSHEER; Aalt Bast; Wim J F van der Vijgh
Possible (enzymatic) routes and biological sites for metabolic reduction of BNP7787, a new protector against cisplatin-induced side-effects.
Biochemical pharmacology 2004;68(3):493-502.
2004: Miranda Verschraagen; Epie Boven; Emine Torun; C A M Erkelens; FREDERICK HAUSHEER; Wim J F van der Vijgh
Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats.
British journal of cancer 2004;90(8):1654-9.
2003: Miranda Verschraagen; Epie Boven; Rita Ruijter; Kasper van der Born; Johannes Berkhof; FREDERICK HAUSHEER; Wim J F van der Vijgh
Pharmacokinetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites.
Clinical pharmacology and therapeutics 2003;74(2):157-69.
2003: Miranda Verschraagen; Epie Boven; Ivon Zegers; FREDERICK HAUSHEER; Wim J F van der Vijgh
Pharmacokinetics of BNP7787 and its metabolite mesna in plasma and ascites: a case report.
Cancer chemotherapy and pharmacology 2003;51(6):525-9.
2003: Miranda Verschraagen; Marc A Kedde; FREDERICK HAUSHEER; Wim J F van der Vijgh
The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG.
Cancer chemotherapy and pharmacology 2003;51(6):499-504.
2003: Miranda Verschraagen; T H Ursula Zwiers; Emine Torun; Martin G Donker; Nico J Reinhoud; Wim J F van der Vijgh
Simultaneous determination of BNP7787 and its metabolite mesna in plasma and tissue by micro-HPLC with a dual electrochemical detector.
Journal of pharmaceutical sciences 2003;92(5):1040-50.
2003: Miranda Verschraagen; Marjolein Bosma; T H Ursula Zwiers; Emine Torun; Wim J F van der Vijgh
Quantification of mesna and total mesna in kidney tissue by high-performance liquid chromatography with electrochemical detection.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2003;783(1):33-42.
2002: Miranda Verschraagen; Kasper van der Born; T H Ursula Zwiers; Wim J F van der Vijgh
Simultaneous determination of intact cisplatin and its metabolite monohydrated cisplatin in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2002;772(2):273-81.
2002: Epie Boven; Miranda Verschraagen; Theresia M Hulscher; C A M Erkelens; FREDERICK HAUSHEER; HERBERT PINEDO; Wim J F van der Vijgh
BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts.
European journal of cancer (Oxford, England : 1990) 2002;38(8):1148-56.
2001: Miranda Verschraagen; T H Ursula Zwiers; P E de Koning; J Welink; Wim J F van der Vijgh
Quantification of BNP7787 (dimesna) and its metabolite mesna in human plasma and urine by high-performance liquid chromatography with electrochemical detection.
Journal of chromatography. B, Biomedical sciences and applications 2001;753(2):293-302.
1999: Miranda Verschraagen; C H Koks; J H M Schellens; Jos H Beijnen
P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil.
Pharmacological research : the official journal of the Italian Pharmacological Society 1999;40(4):301-6.